CD8A and neoplasm: Another study was documented that mice with osteosarcoma tumors were treated with DCs and doxorubicin in combination and showed an increased frequency of CD8+ T cells in metastatic tumors and suppression of metastatic growth as well as increased expression of CRT and the release of HMGB1 from tumor tissues.